Cite

HARVARD Citation

    D'Silva, A. et al. (2022). Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy. Annals of clinical and translational neurology. 9 (3), pp. 339-350. [Online]. 
  
Back to record